The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PCR-based comprehensive genomic profiling (PCR-CGP): Feasibility from >20,000 tumor tissue specimens (TTS) and predicted impact on actionable biomarker identification versus hybrid capture (H)-CGP and plasma (P)-CGP.
 
Dan Rhodes
Employment - Javelin Oncology; Strata Oncology
Leadership - Javelin Oncology; Strata Oncology
Stock and Other Ownership Interests - Javelin Oncology; Strata Oncology
Patents, Royalties, Other Intellectual Property - I am paid royalties from the University of Michigan on license revenues related to a patent on prostate cancer gene fusions
 
Daniel H Hovelson
Employment - Strata Oncology
Consulting or Advisory Role - TERUMO
Travel, Accommodations, Expenses - Thermo Fisher Scientific
 
Jennifer Marie Suga
No Relationships to Disclose
 
Daniel M. Anderson
No Relationships to Disclose
 
Elizabeth Claire Dees
Consulting or Advisory Role - G1 Therapeutics; Novartis (I); Strata Oncology
Research Funding - Bayer; Cerulean Pharma; Genentech/Roche; H3 Biomedicine; Lilly; Merck; Meryx Pharmaceuticals; Novartis; Pfizer
Travel, Accommodations, Expenses - G1 Therapeutics
 
Han A. Koh
Research Funding - Lilly (Inst)
 
Mark E. Burkard
Consulting or Advisory Role - Novartis; Pointcare genomics; Strata Oncology
Research Funding - Abbvie (Inst); Loxo (Inst); Merck (Inst); Puma Biotechnology (Inst); Strata Oncology (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent for a method to detect recombination events with CRISPR-mediated editing.; I have patent for implantable/localized drug delivery device that can sample the tumor microenvironment and deliver drug.
 
Jamil Khatri
No Relationships to Disclose
 
Malek M. Safa
No Relationships to Disclose
 
Marc Ryan Matrana
Consulting or Advisory Role - Strata Oncology
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech; Merck
 
Eddy Shih-Hsin Yang
Consulting or Advisory Role - AstraZeneca; Strata Oncology
Research Funding - Clovis Oncology (Inst); Lilly (Inst); Novartis (Inst)
Other Relationship - Strata Oncology
 
Alex R. Menter
No Relationships to Disclose
 
Benjamin Marshall Parsons
Consulting or Advisory Role - Amgen; Celgene
Speakers' Bureau - Amgen; Celgene
 
Jennifer Nadine Slim
No Relationships to Disclose
 
Jayson Falkner
Employment - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
 
Travis Reeder
Employment - Strata Oncology
 
Hana Vakil
Employment - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
 
Kat Kwiatkowski
Employment - Strata Oncology
Stock and Other Ownership Interests - Editas Medicine; Epizyme; Intuitive Surgical; Loxo; Strata Oncology
 
Bryan Johnson
Employment - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
 
Scott A. Tomlins
Employment - Strata Oncology
Leadership - Strata Oncology
Stock and Other Ownership Interests - Javelin Oncology; Strata Oncology
Consulting or Advisory Role - Astellas Medivation; Janssen; Strata Oncology
Research Funding - Astellas Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am a coauthor on a patent issued to the University of Michigan on ETS gene fusions in prostate cancer. The diagnostic field of use has been licensed to Hologic/Gen-Probe Inc., who has sublicensed some rights to Ventana Medical Systems/Roche.
Travel, Accommodations, Expenses - Strata Oncology